MoneyWorks4Me

Biocon informs about updates on Financial Results

11 Jul 2014 Evaluate

With reference to the earlier announcement dated April 25, 2014 regarding Q4 & FY14 results wherein the discrepancies in Part II (Shareholding Details) of the Financial Result for the quarter and year ended March 31, 2014. In this regard, Biocon has now informed that difference in numbers under Particulars of Shareholders in the column pertaining to year ended March 31, 2014 was due to typographical mistake. The correct numbers were however carried in the consolidated financial results as intimated to the Stock Exchanges. The Company has rectified the Shareholding details [Part II] information in the Standalone results.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..